Company intelligence / Profile preview

Mediterranean Pharmaceutical Company

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Mediterranean Pharmaceutical Company (MPC) is a Jordan-based pharmaceutical manufacturer established to develop, produce, and market high-quality generic medicines. The company operates a modern manufacturing facility that complies with international Good Manufacturing Practice (GMP) standards, serving both domestic and regional Middle Eastern markets. MPC's product portfolio spans several therapeutic categories, including anti-infectives, cardiovascular treatments, and gastrointestinal medications. By focusing on affordable healthcare solutions, the company plays a significant role in the regional pharmaceutical supply chain.

Therapeutic areas: CardiovascularEndocrinologyInfectious DiseasesRheumatologyPulmonologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Mediterranean Pharmaceutical Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mediterranean Pharmaceutical Company.